News

As pet obesity becomes a growing concern, scientists are exploring weight-loss solutions for dogs, drawing inspiration from ...
From tiny plates to mini martinis, this is how menus are being shaped by a weight-loss era - FOOD FOCUS: From luxe mini menus ...
Multiple lawsuits have been filed against the makers of the popular weight-loss drug. Litigants cite blindness and other side-effects.
A rumor that pharmaceutical companies behind popular weight-loss and diabetes medications like Ozempic faced lawsuits totaling more than $2 billion circulated online in August 2025.
Worker-led protests erupted at Microsoft headquarters this week as the tech company promises an “urgent” review of the ...
The U.S. Food and Drug Administration (FDA) has approved Novo Nordisk's popular weight-loss drug Wegovy to treat a serious ...
GoodRx and Novo Nordisk are partnering to lower costs for Ozempic and Wegovy. Patients can use GoodRx to access ...
In an effort to address the state’s obesity epidemic and subsequently address the health effects associated with it, the Mississippi Legislature is considering allowing GLP-1 medications such as ...
Doustdar, a longtime company insider, took up the chief executive role on Aug. 7, a week after Novo Nordisk cut its outlook for the second time this year blaming competition from copycat versions of ...
As more people take GLP-1 drugs like Ozempic or Wegovy for weight loss, surgeons are seeing an increase in demand for cosmetic procedures.
GLP-1 weight-loss drugs are creating “mortality slippage” in life insurance which is a costly problem that's forcing insurers to rethink how they underwrite.